Keyphrases
Clinical High Risk
100%
Non-persistence
100%
Patients with Cardiovascular Diseases
100%
Heart Failure Hospitalization
50%
Myocardial Infarction
33%
Hazard Ratio
33%
Cardiovascular Mortality
33%
Female Gender
16%
Randomized Placebo-controlled Trial
16%
Improved Outcomes
16%
Old Age
16%
Early Events
16%
Diabetes
16%
Cardiovascular Events
16%
Physical Activity
16%
First Year
16%
Composite Endpoint
16%
Stroke History
16%
Vicious Circle
16%
Non-fatal
16%
Non-adherence
16%
Transient Ischemic Attack
16%
Telmisartan
16%
Ramipril
16%
Non-cardiovascular
16%
Failure Hazard
16%
Subsequent Events
16%
Medication Persistence
16%
INIS
patients
100%
cardiovascular diseases
100%
risks
100%
heart failure
75%
myocardial infarction
50%
death
50%
hazards
50%
females
25%
comparative evaluations
25%
education
25%
adjustments
25%
ischemia
25%
Nursing and Health Professions
Cardiovascular Disease
100%
Cerebrovascular Accident
100%
Congestive Heart Failure
100%
Heart Infarction
66%
Hazard Ratio
66%
Placebo
33%
Transient Ischemic Attack
33%
Ramipril
33%
Telmisartan
33%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Cerebrovascular Accident
100%
Cardiovascular Disease
100%
Heart Infarction
66%
Placebo
33%
Ramipril
33%
Transient Ischemic Attack
33%
Telmisartan
33%
Neuroscience
Cerebrovascular Accident
100%
Myocardial Infarction
66%
Transient Ischemic Attack
33%
Placebo
33%
Telmisartan
33%
Ramipril
33%